150 related articles for article (PubMed ID: 30893598)
1. Enhanced Renewal of Erythroid Progenitors in Myelodysplastic Anemia by Peripheral Serotonin.
Sibon D; Coman T; Rossignol J; Lamarque M; Kosmider O; Bayard E; Fouquet G; Rignault R; Topçu S; Bonneau P; Bernex F; Dussiot M; Deroy K; Laurent L; Callebert J; Launay JM; Georgin-Lavialle S; Courtois G; Maroteaux L; Vaillancourt C; Fontenay M; Hermine O; Côté F
Cell Rep; 2019 Mar; 26(12):3246-3256.e4. PubMed ID: 30893598
[TBL] [Abstract][Full Text] [Related]
2. In vitro proliferation and differentiation of erythroid progenitors from patients with myelodysplastic syndromes: evidence for Fas-dependent apoptosis.
Claessens YE; Bouscary D; Dupont JM; Picard F; Melle J; Gisselbrecht S; Lacombe C; Dreyfus F; Mayeux P; Fontenay-Roupie M
Blood; 2002 Mar; 99(5):1594-601. PubMed ID: 11861273
[TBL] [Abstract][Full Text] [Related]
3. Enhancing mitochondrial function in vivo rescues MDS-like anemia induced by pRb deficiency.
Sen T; Jain M; Gram M; Mattebo A; Soneji S; Walkley CR; Singbrant S
Exp Hematol; 2020 Aug; 88():28-41. PubMed ID: 32629063
[TBL] [Abstract][Full Text] [Related]
4. Expression of CD44 and CD35 during normal and myelodysplastic erythropoiesis.
Laranjeira P; Rodrigues R; Carvalheiro T; Constanço C; Vitória H; Matarraz S; Trindade H; Órfão A; Paiva A
Leuk Res; 2015 Mar; 39(3):361-70. PubMed ID: 25582385
[TBL] [Abstract][Full Text] [Related]
5. BOK promotes erythropoiesis in a mouse model of myelodysplastic syndrome.
Kang SH; Perales O; Michaud M; Katz SG
Ann Hematol; 2019 Sep; 98(9):2089-2096. PubMed ID: 31203423
[TBL] [Abstract][Full Text] [Related]
6. In vitro studies of erythropoietin-dependent regulation of erythropoiesis in myelodysplastic syndromes.
Merchav S; Nielsen OJ; Rosenbaum H; Sharon R; Brenner B; Tatarsky I; Scigalla P; Wieczorek L
Leukemia; 1990 Nov; 4(11):771-4. PubMed ID: 2232891
[TBL] [Abstract][Full Text] [Related]
7. Over-expression of tumor necrosis factor-alpha in bone marrow biopsies from patients with myelodysplastic syndromes: relationship to anemia and prognosis.
Stifter G; Heiss S; Gastl G; Tzankov A; Stauder R
Eur J Haematol; 2005 Dec; 75(6):485-91. PubMed ID: 16313260
[TBL] [Abstract][Full Text] [Related]
8. The fraction of CD117/c-KIT-expressing erythroid precursors predicts ESA response in low-risk myelodysplastic syndromes.
Raimbault A; Itzykson R; Willems L; Rousseau A; Chapuis N; Mathis S; Clauser S; Radford-Weiss I; Bouscary D; Fontenay M; Kosmider O; Bardet V
Cytometry B Clin Cytom; 2019 May; 96(3):215-222. PubMed ID: 30963682
[TBL] [Abstract][Full Text] [Related]
9. Ineffective erythropoiesis with reduced red blood cell survival in serotonin-deficient mice.
Amireault P; Hatia S; Bayard E; Bernex F; Collet C; Callebert J; Launay JM; Hermine O; Schneider E; Mallet J; Dy M; Côté F
Proc Natl Acad Sci U S A; 2011 Aug; 108(32):13141-6. PubMed ID: 21788492
[TBL] [Abstract][Full Text] [Related]
10. In vitro stimulation of erythropoiesis by stem cell factor alone in myelodysplastic syndrome patients with elevated endogenous erythropoietin serum levels.
Zwierzina H; Bammer T; Rollinger-Holzinger I; Herold M; Fenaux P; Nüssler V; Hoflehner E; Geissler D
Clin Cancer Res; 1996 Jun; 2(6):1031-8. PubMed ID: 9816264
[TBL] [Abstract][Full Text] [Related]
11. GATA-1 transcription factor is up-regulated in bone marrow hematopoietic progenitor CD34(+) and erythroid CD71(+) cells in myelodysplastic syndromes.
Maratheftis CI; Bolaraki PE; Voulgarelis M
Am J Hematol; 2007 Oct; 82(10):887-92. PubMed ID: 17570514
[TBL] [Abstract][Full Text] [Related]
12. TET2 deficiency leads to stem cell factor-dependent clonal expansion of dysfunctional erythroid progenitors.
Qu X; Zhang S; Wang S; Wang Y; Li W; Huang Y; Zhao H; Wu X; An C; Guo X; Hale J; Li J; Hillyer CD; Mohandas N; Liu J; Yazdanbakhsh K; Vinchi F; Chen L; Kang Q; An X
Blood; 2018 Nov; 132(22):2406-2417. PubMed ID: 30254129
[TBL] [Abstract][Full Text] [Related]
13. The effect of stem-cell factor, interleukin-3 and erythropoietin on in vitro erythropoiesis in myelodysplastic syndromes.
Verbeek W; Vehmeyer K; Wörmann B; Hiddemann W
J Cancer Res Clin Oncol; 1995; 121(6):338-42. PubMed ID: 7797598
[TBL] [Abstract][Full Text] [Related]
14. PPAR-α and glucocorticoid receptor synergize to promote erythroid progenitor self-renewal.
Lee HY; Gao X; Barrasa MI; Li H; Elmes RR; Peters LL; Lodish HF
Nature; 2015 Jun; 522(7557):474-7. PubMed ID: 25970251
[TBL] [Abstract][Full Text] [Related]
15. Kit ligand improves in vitro erythropoiesis in myelodysplastic syndrome.
Backx B; Broeders L; Löwenberg B
Blood; 1992 Sep; 80(5):1213-7. PubMed ID: 1381239
[TBL] [Abstract][Full Text] [Related]
16. Characterization, regulation, and targeting of erythroid progenitors in normal and disordered human erythropoiesis.
Dulmovits BM; Hom J; Narla A; Mohandas N; Blanc L
Curr Opin Hematol; 2017 May; 24(3):159-166. PubMed ID: 28099275
[TBL] [Abstract][Full Text] [Related]
17. Blockade of IL-22 signaling reverses erythroid dysfunction in stress-induced anemias.
Raundhal M; Ghosh S; Myers SA; Cuoco MS; Singer M; Carr SA; Waikar SS; Bonventre JV; Ritz J; Stone RM; Steensma DP; Regev A; Glimcher LH
Nat Immunol; 2021 Apr; 22(4):520-529. PubMed ID: 33753942
[TBL] [Abstract][Full Text] [Related]
18. Thrice weekly azacitidine does not improve hematological responses in lower-risk myelodysplastic syndromes: a study of the Hoosier Oncology Group.
Sayar H; Chan RJ; Orschell CM; Chan EM; Yu Z; Hood D; Plett A; Yang Z; Hui CL; Nabinger SC; Kohlbacher KJ; West ES; Walter A; Sampson C; Wu J; Cripe LD
Leuk Res; 2011 Aug; 35(8):1108-10. PubMed ID: 21420732
[TBL] [Abstract][Full Text] [Related]
19. Management of anemia in low-risk myelodysplastic syndromes treated with erythropoiesis-stimulating agents newer and older agents.
Castelli R; Schiavon R; Rossi V; Deliliers GL
Med Oncol; 2018 Apr; 35(5):76. PubMed ID: 29675620
[TBL] [Abstract][Full Text] [Related]
20. Vitamin K2 modulates differentiation and apoptosis of both myeloid and erythroid lineages.
Sada E; Abe Y; Ohba R; Tachikawa Y; Nagasawa E; Shiratsuchi M; Takayanagi R
Eur J Haematol; 2010 Dec; 85(6):538-48. PubMed ID: 20887388
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
